These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1548041)

  • 1. Nonapeptide corresponding to the sequence 27-35 of the mature human IL-2 efficiently competes with rIL-2 for binding to thymocyte receptors [corrected].
    Zav'yalov VP; Navolotskaya EV; Isaev IS; Kaurov OA; Kolobov AA; Vasilenko RN; Galaktionov VG; Denesyuk AI
    Immunol Lett; 1992 Feb; 31(3):285-8. PubMed ID: 1548041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization in human interleukin 2 of the binding site to the alpha chain (p55) of the interleukin 2 receptor.
    Sauvé K; Nachman M; Spence C; Bailon P; Campbell E; Tsien WH; Kondas JA; Hakimi J; Ju G
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4636-40. PubMed ID: 2052547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The octapeptide corresponding to the region of the highest homology between alpha-interferon and thymosin-alpha 1 effectively competes with both cytokines for common high-affinity receptors on murine thymocytes.
    Zav'yalov VP; Navolotskaya EV; Abramov VM; Galaktionov VG; Isaev IS; Kaurov OA; Kozhich AT; Maiorov VA; Prusakov AN; Vasilenko RN
    FEBS Lett; 1991 Jan; 278(2):187-9. PubMed ID: 1846821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic epitopes of the p55 chain of the IL-2 receptor. Relationships to high-affinity IL-2 binding and modulation of the p55 chain.
    Wong JT; Schott E; Sabga EM; Kielpinski GG; Colvin RB
    Transplantation; 1990 Mar; 49(3):587-96. PubMed ID: 1690471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
    Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
    Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
    Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing patterns of lymphocyte proliferation, IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni.
    Yamashita T; Boros DL
    J Immunol; 1990 Jul; 145(2):724-31. PubMed ID: 1973188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of low-, intermediate-, and high-affinity IL-2 receptors on B cell lines derived from patients with undifferentiated lymphoma of Burkitt's and non-Burkitt's types.
    Benjamin D; Rosolen A; Wormsley SB; DeBault LE; Colamonici OR
    Cell Immunol; 1990 Aug; 129(1):112-24. PubMed ID: 2364438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical characterization of antigenic domains on human IL-2: spatially distinct epitopes are associated with binding to the p55 and p70 subunits of IL-2 receptor.
    Rebollo A; De Groote D; Baudrihay M; Thèze J; Jankovic DL
    Mol Immunol; 1992 Jan; 29(1):119-30. PubMed ID: 1370571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of both Tac and non-Tac interleukin 2-binding peptides in the interleukin 2-dependent proliferation of human tumor-infiltrating lymphocytes.
    Yagita M; Itoh K; Tsudo M; Schaub LB; Platsoucas CD; Balch CM; Grimm EA
    Cancer Res; 1989 Mar; 49(5):1154-9. PubMed ID: 2783885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse interleukin-2 structure-function studies: substitutions in the first alpha-helix can specifically inactivate p70 receptor binding and mutations in the fifth alpha-helix can specifically inactivate p55 receptor binding.
    Zurawski SM; Zurawski G
    EMBO J; 1989 Sep; 8(9):2583-90. PubMed ID: 2583124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species specificity of interleukin 2 binding to individual receptor components.
    Collins MK
    Eur J Immunol; 1989 Aug; 19(8):1517-20. PubMed ID: 2789143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
    Jankovic DL; Rebollo A; Kumar A; Gibert M; Thèze J
    J Immunol; 1990 Dec; 145(12):4136-44. PubMed ID: 2258612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-internalization of the p55 and p70 subunits of the high-affinity human interleukin 2 receptor. Evidence for a stable ternary receptor complex.
    Fung MR; Ju G; Greene WC
    J Exp Med; 1988 Nov; 168(5):1923-8. PubMed ID: 3263468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of IL-2 interaction with p75 and p55 receptor molecules in the stimulation of cell proliferation.
    Perkins GR; Flemming CL; Kabat D; Collins MK
    Int Immunol; 1993 May; 5(5):541-9. PubMed ID: 8318457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IL-2 receptor alpha-chain alters the binding of IL-2 to the beta-chain.
    Arima N; Kamio M; Okuma M; Ju G; Uchiyama T
    J Immunol; 1991 Nov; 147(10):3396-401. PubMed ID: 1940342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of low and high affinity binding sites with fluoresceinated human recombinant interleukin-2.
    Harel-Bellan A; Mishal Z; Willette-Brown J; Farrar WL
    J Immunol Methods; 1989 Apr; 119(1):127-33. PubMed ID: 2496169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding.
    Voss SD; Robb RJ; Weil-Hillman G; Hank JA; Sugamura K; Tsudo M; Sondel PM
    J Exp Med; 1990 Oct; 172(4):1101-14. PubMed ID: 1698909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptors.
    Chu JW; Sharom FJ
    Immunology; 1993 May; 79(1):10-7. PubMed ID: 8509130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptides as putative therapeutic agents in transplantation medicine: application of PEPSCAN to the identification of functional sequences in the extracellular domain of the interleukin-2 receptor beta chain (IL-2Rbeta).
    Dionyssopoulou H; Mouzaki A; Slootstra J; Puijk W; Meloen R; Cordopatis P; Sotiropoulou G
    J Immunol Methods; 2000 Jul; 241(1-2):83-95. PubMed ID: 10915851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.